Updated:
Harper Bernays
Peter James Harper established Harper Bernays to deliver investment management and advisory services to Australian high-net-worth families and not-for-profit...
Harper Bernays
Peter James Harper established Harper Bernays to deliver investment management and advisory services to Australian high-net-worth families and not-for-profit entities. The firm concentrates on publicly listed securities while maintaining capacity for private-market exposure. Harper Bernays deploys capital through direct co-investments, fund-of-funds commitments, and private-equity mandates. Its sector focus includes healthcare services and EdTech, with additional activity in biotechnology via the jointly owned HB Biotechnology Limited. Geographic reach spans Asia, Europe, North America, and Oceania. The firm operates the Harper Bernays Charitable Trust and supports the AMA Victoria Charitable Foundation. Alex Pikoulas has served as CEO; Dr. Charles Williams leads the biotechnology vehicle. Tony Scenna participated in the original founding before moving to Selector Funds Management.
General information
Firm type
Multi Family Office
Year founded
—
AUM
Undisclosed
Location
Region
Oceania
Country
Australia
City
Sydney
Corporate office
Level 1, 50 Pitt Street, Sydney, NSW 2000, Australia
Principals
Peter James Harper
Executive Chairman and Founder
Dr. Charles Williams
MD and CIO of HB Biotechnology Limited
Alex Pikoulas
CEO
Tony Scenna
Co-founder
Sector focus
Frequently asked questions
Who runs investment decisions at Harper Bernays?
Peter James Harper serves as Executive Chairman. Alex Pikoulas has acted as CEO. Dr. Charles Williams oversees the biotechnology vehicle HB Biotechnology Limited.
Does Harper Bernays participate in fund commitments or only direct deals?
The firm uses both fund-of-funds commitments and direct co-investments or SPVs. It also maintains philanthropic structures through the Harper Bernays Charitable Trust.
Which sectors does Harper Bernays target?
Confirmed focuses include healthcare services and EdTech. The firm also holds exposure to biotechnology through its joint ownership of HB Biotechnology Limited.
Where does Harper Bernays invest geographically?
The firm maintains allocations across Asia, Europe, North America, and Oceania.
How is Harper Bernays related to HB Biotechnology Limited?
Harper Bernays jointly owns HB Biotechnology Limited with Dr. Charles Williams, who serves as its managing director and CIO.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: